Felbamate

Felbamate is a medicine used to treat seizures in people with severe epilepsy. It works by blocking certain nerve signals. It's a strong medicine, so it's usually only used when other treatments haven't worked.

Brand names:Felbatol, Taloxa
Medication

What people taking Felbamate report

Every report comes from a Lived member, sent anonymously.

Have you tried Felbamate for Lennox Gastaut Syndrome?

NameHow it went

About Felbamate

What It's For

Felbamate, sold under the brand name Felbatol and as a generic, is a prescription antiseizure medicine reserved for severe epilepsy that has not responded well enough to other treatments. In adults, it is approved for focal seizures (also called partial seizures), which start in one area of the brain and may or may not spread more widely. It can be used on its own or together with other seizure medicines. In children, it is approved only as an add-on treatment for the seizures of Lennox-Gastaut syndrome, a severe childhood epilepsy with several seizure types, including sudden drop attacks, and developmental delays. Felbamate is not a first-choice medicine. It carries a small but serious risk of two potentially fatal reactions: failure of the bone marrow to make blood cells, and failure of the liver. For that reason it is considered only when seizures are severe enough that better control is judged worth that risk, and only after the risks have been explained and the patient, parent or guardian has signed a written acknowledgment.

How It Works

Seizures happen when groups of brain cells fire in an excessive, synchronized burst. Exactly how felbamate calms this activity is not known. Laboratory studies show that it blocks part of the NMDA receptor, a docking site for glutamate, the brain's main excitatory chemical messenger, and has weaker effects linked to GABA, the brain's main calming messenger. Animal tests suggest it both makes a seizure harder to start and limits how far one spreads. These findings help explain why it works against several seizure types, but they do not predict who will benefit.

Dosage & Administration

Felbamate is taken by mouth three or four times a day, as a tablet or as a liquid suspension that needs to be shaken well before each dose. The prescriber starts with a lower dose and raises it in steps over a few weeks. Children's doses are calculated from body weight. Because felbamate changes the blood levels of several other seizure medicines, those medicines are usually reduced, often by about a fifth to a third, when felbamate is started, and adjusted again as its dose rises. Many early side effects ease once those doses come down. People with kidney problems generally need lower doses, so the prescriber should know about any kidney disease. Do not stop felbamate suddenly or change the dose without talking to the prescriber. Stopping a seizure medicine abruptly can bring on more frequent seizures.

Side Effects

The most common side effects are loss of appetite, weight loss, nausea, vomiting, trouble sleeping and headache. When felbamate is taken alongside other seizure medicines, dizziness and sleepiness are also common, partly because of how the medicines affect each other's levels. Alcohol and other sedating medicines can make drowsiness and dizziness worse. The rare but serious reactions involve the blood and the liver. Call the prescriber right away for signs that the bone marrow may not be making enough blood cells: fever, sore throat or infections that keep coming back or will not clear, easy bruising, small red or purple spots on the skin, bleeding gums or nosebleeds, or severe tiredness or weakness. Also call right away for signs of liver injury: yellowing of the skin or the whites of the eyes, dark urine, pain on the upper right side of the abdomen, or new nausea, vomiting and loss of appetite that come with feeling generally unwell.

Interactions & Warnings

Felbamate carries an FDA boxed warning, the agency's strongest, for two reactions. The first is aplastic anemia, in which the bone marrow stops producing enough red cells, white cells and platelets. The risk may be more than 100 times higher than in the general population, and the condition can be fatal. In reported cases it appeared 5 to 30 weeks after starting, and the risk can continue for an unknown time after the medicine is stopped. Routine blood counts cannot reliably prevent it, though they sometimes catch changes early. The second is acute liver failure, which has led to death or liver transplant and has appeared as early as three weeks into treatment. Felbamate should not be used by anyone with a past blood disorder or liver problems, or with an allergy to felbamate or related carbamate compounds. A person who developed liver injury on felbamate should not take it again. Felbamate raises blood levels of the seizure medicines phenytoin, valproate and phenobarbital, which can cause side effects unless their doses are lowered. It lowers carbamazepine levels while raising one of its active breakdown products, and phenytoin and carbamazepine in turn lower felbamate levels. These shifts are why doses are adjusted together. Felbamate may also lower the level of the progestin in some birth control pills, so contraception is worth reviewing with the prescriber. Like other antiseizure medicines, felbamate may increase suicidal thoughts or behavior in a small number of people. New or worsening depression, unusual mood or behavior changes, or thoughts of self-harm should be reported to the prescriber right away. It is not known whether felbamate harms an unborn baby, so anyone pregnant or planning pregnancy should discuss it with the prescriber; a national registry collects information on seizure medicines used in pregnancy.

What to Expect

Before treatment starts, the prescriber goes through the risks in detail and checks a full blood count, including platelets, and liver enzymes (AST and ALT, blood tests that rise when liver cells are damaged). Liver tests are repeated periodically, and felbamate is stopped if either enzyme reaches twice the upper limit of normal or symptoms suggest liver trouble. Blood counts are checked often during treatment and for some time after it ends. Any blood abnormality usually prompts a hematologist's (blood specialist's) opinion and stopping the drug. How much felbamate helps varies widely. In the trial that led to its approval for Lennox-Gastaut syndrome, total seizures fell by about a quarter and drop seizures by 44% over 10 weeks, while seizures did not improve on placebo. For drug-resistant focal epilepsy, a 2022 review of four small trials found the results too limited and inconsistent to show a reliable benefit, so the decision rests heavily on how an individual responds. The care team reviews over time whether seizure control is good enough to justify the ongoing risk, and if felbamate is stopped, it is tapered rather than halted.

Questions to Ask Your Doctor

  1. 1.Which other treatments have we tried or ruled out, and why is felbamate worth its risks for me or my child?
  2. 2.How often will blood counts and liver tests be done, and for how long after stopping?
  3. 3.How will the doses of my other seizure medicines change, and will their blood levels be checked?
  4. 4.How will we judge whether felbamate is working, and when would we decide to stop it?
  5. 5.Does felbamate affect my birth control, and what should I do if I am planning a pregnancy?

Last reviewed • Oct 2026

Educational content, not medical advice.